Infirst’s Flarin enters trial for treating COVID-19

4 June 2020 - Deborah Wilkes

Archived

A clinical trial in the UK is evaluating the efficacy of Infirst’s Flarin as a treatment for certain symptoms experienced by patients hospitalised with COVID-19.

Click tags below for more information on topics:

Flarin COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: